Bond Biosciences

Parkville, MO · Founded 2015 · Privately Held (backing)

Developer of small molecule-based therapeutics designed to prevent and treat ion-related human diseases. Bond Biosciences is based in Parkville, MO and was founded in 2015. Its last reported valuation was $122 million in Jan 2022. It has raised $17.1 million across 2 recorded rounds; the latest was a $5.9 million early-stage round in Apr 2026.

Last reported valuation
$121.8M
Oct 2026
Priced at
—
Total raised
$17.1M
Last round
Early Stage VC
Apr 2026

Who backs Bond Biosciences?

5 investors
InvestorType
National Institutes of HealthOther
BioGenerator VenturesVenture capital
Collage Venture Partners—
Emerald Bioventures—
Transhuman Capital—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Bond Biosciences investors

5 investors are on record for Bond Biosciences, including National Institutes of Health, BioGenerator Ventures, Collage Venture Partners and Emerald Bioventures. The early-stage round in Apr 2026 drew 83 investors.

Free account
More of Bond Biosciences with a free account
  • ·Watch Bond Biosciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 5 firms already write checks for companies like Bond Biosciences. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View